Cargando…
Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in Non-VA and VA Populations
Background: Chronic hepatitis C viral (HCV) infection affects millions of Americans. Health care systems face complex choices between highly efficacious, costly treatments. This study assessed the cost-effectiveness of treatments for chronic, genotype 1 HCV monoinfected, treatment-naïve individuals...
Autores principales: | Liu, Shan, Barnett, Paul G., Holodniy, Mark, Lo, Jeanie, Joyce, Vilija R., Gidwani, Risha, Asch, Steven M., Owens, Douglas K., Goldhaber-Fiebert, Jeremy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942888/ https://www.ncbi.nlm.nih.gov/pubmed/29756049 http://dx.doi.org/10.1177/2381468316671946 |
Ejemplares similares
-
Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
por: Liu, Shan, et al.
Publicado: (2013) -
Va, Pensiero
por: Kim, Tae-Il
Publicado: (2011) -
Rien va
por: Landolfi, Tommaso, 1908-1979 -
Does Antimicrobial Prescription Data Improve Influenza Surveillance in VA?
por: Schirmer, Patricia, et al.
Publicado: (2013) -
¿Adónde va Francia? ¿Adónde va Europa?
por: Caillaux, Joseph, 1863-1944
Publicado: (1923)